Tissue engineering of retina through high resolution 3-dimentional inkjet bioprinting.
The mammalian retina contains multiple cellular layers, each carrying out a specific task. Such a controlled organization should (Yue et al., 2015)be considered as a crucial factor for designing retinal therapies. The maintenance of retinal layered complexity through the use of scaffold-free techniques has recently emerged as a promising approach for clinical ocular tissue engineering. In an attempt to fabricate such layered retinal model, we are proposing herein a unique inkjet bioprinting system applied to the deposition of a photoreceptor cell (PRs) layer on top of a bioprinted retinal pigment epithelium (RPE), in a precise arrangement and without any carrier material. The results showed that, after bioprinting, both RPE and PRs were well positioned in a layered structure and expressed their structural markers, which was further demonstrated by ZO1, MITF, rhodopsin, opsin B, opsin R/G and PNA immunostaining, 3 days after bioprinting. We also showed that considerable amounts of human vascular endothelial growth factor (hVEGF) were released from the RPE printed layer, which confirmed formation of a functional RPE monolayer after bioprinting. Microstructures of bioprinted cells as well as phagocytosis of photoreceptor outer segments by apical RPE microvilli was finally established through transmission electron microscopy (TEM) imaging. In summary, using this carrier-free bioprinting method, it was possible to develop a reasonable in vitro retina model for studding some sight-threatening diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP).